INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines

Pomerantz LLP announced that a class action lawsuit has been filed against Capricor Therapeutics (NASDAQ: CAPR). The filing is a negative overhang for investors, though no financial figures or allegations were provided in the news item. Expect limited near-term impact until case details and any potential financial implications become clear.